School of Medicine
Showing 101-120 of 507 Results
-
Alex Maurice Dussaq
Clinical Assistant Professor, Pathology
BioAlex Maurice Dussaq, M.D., Ph.D., is an assistant professor of breast pathology and an associate director of pathology informatics. Dr. Dussaq holds a B.S. in Mathematics and Biochemistry from University of Nevada, Reno and an M.D./Ph.D. from University at Alabama, Birmingham. His Ph.D. focused on novel platform informatics and statistical analysis. He completed a Pathology residency and fellowships at Stanford in breast pathology and clinical informatics. Dr. Dussaq's research interests include the implementation and creation of workflow tools for surgical pathology and lab. He is particularly interested in whole slide image management systems and the future applications of artificial intelligence and large language models in pathology and medicine..
-
Alex Edwin
Life Science Research Professional 1, Pathology - Montine Lab
BioAlex received his bachelor's degree in neuroscience from Santa Clara University. He also minored in Spanish and Biology. During his time there, he studied fMRI data to identify patterns of resting-state functional brain connectivity in individuals with Autism Spectrum Disorder. Currently, he utilizes hippocampal slice cultures, cell cultures, and biochemical assays to screen small molecule drug compounds. His research is conducted with hopes to identify novel therapeutics for Alzheimer's disease, Parkinson's disease, and X-linked creatine deficiency.
-
Ifeanyichukwu Emmanuel Eke
Postdoctoral Scholar, Pathology
BioI am a chemical biologist with a broad interest in defining the mechanisms-of-action of novel compounds that can be used as potential drugs or diagnostic probes for different bacterial and viral infections. In addition to my flair for research, I am passionate about teaching, mentorship, leadership, and entrepreneurship.
-
Lawrence Eng
Professor (Research) of Pathology, Emeritus
Current Research and Scholarly InterestsAstrocytes make up a substantial proportion of the central nervous system (CNS) and participate in a variety of important physiologic and pathologic processes. They are characterized by vigorous response to diverse neurologic insults.
-
Edgar Engleman
Professor of Pathology and of Medicine (Immunology and Rheumatology)
On Leave from 07/01/2025 To 06/30/2026Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
Marcelo Fernandez Vina
Professor of Pathology
BioMarcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and Past President of the International HLA & Immunogenetics Workshop.
-
Sebastian Fernandez-Pol
Clinical Associate Professor, Pathology
BioDr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.
-
Michael S. Fernandopulle
Affiliate, Department Funds
Resident in PathologyBioMichael Fernandopulle, M.D., Ph.D., is a resident in clinical pathology at Stanford University. During his graduate work at the NIH with Dr. Michael Ward and at Cambridge with Dr. Peter St. George-Hyslop, he uncovered novel pathways for mRNA localization and local protein synthesis in neurons. He is interested in combining biochemistry, metabolism, and high-throughput cell and subcellular profiling technologies to uncover fundamental principles of aging and neurodegeneration, and to apply these discoveries toward novel diagnostics and therapeutics.
Michael holds an Sc.B. in Chemistry from Brown University, an M.D. from Northwestern University, and a Ph.D. in Neuroscience from the University of Cambridge, Darwin College. -
Andrew Fire
George D. Smith Professor of Molecular and Genetic Medicine and Professor of Pathology and of Genetics
Current Research and Scholarly InterestsWhile chromosomal inheritance provides cells with one means for keeping and transmitting genetic information, numerous other mechanisms have (and remain to be) discovered. We study novel cellular mechanisms that enforce genetic constancy and permit genetic change. Underlying our studies are questions of the diversity of inheritance mechanisms, how cells distinguish such mechanisms as "wanted" versus "unwanted", and of the consequences and applications of such mechanisms in health and disease.
-
Jelle Folkerts
Postdoctoral Scholar, Pathology
BioDr. Folkerts received his master's degree in Drug Innovation from Utrecht University in the Netherlands, during which he spent a year at the Galli lab at Stanford on a Fulbright Scholarship. During this time, Dr. Folkerts played a key role in developing a technology platform employing functional genomics and high-resolution single-cell confocal imaging, enabling the rapid identification of degranulation regulators in primary human mast cells. Following his time at Stanford, Dr. Folkerts studied the regulatory mechanisms of human mast cell activation under the guidance of Rudi Hendriks and Marcus Maurer, earning his Ph.D. in 2022. He then returned to Stanford as a postdoctoral fellow in the Galli lab, where his current research focuses on the identification of human mast cell degranulation regulators using a whole-genome CRISPR knockout library screen, and the validation of these findings using the recently developed technology platform. It is his long-standing goal to contribute to the design and development of specific and effective therapeutic interventions for mast cell-mediated diseases.
-
Ann Folkins
Associate Professor of Pathology
Current Research and Scholarly InterestsDr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.
